GARY STARKEY: Open Payments
NPI 1770561698 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 46 payments from 11 companies in 2025. Trend: 2023 $1,656 · 2024 $1,230 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $450 |
| Janssen Pharmaceuticals, Inc | 7 | $168 |
| ABBVIE INC. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| HARMONY BIOSCIENCES LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: COBENFY, SPRAVATO, INVEGA SUSTENNA, VRAYLAR, FANAPT, ARISTADA, CAPLYTA, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
